Henry Wellcome Building for Molecular Physiology
Nuffield Professor of Clinical Medicine and Head of Department
- Professor of Immunology
Our aim is to understand how the immune system is formed and regulated and the causes of autoimmunity, particularly the systemic autoimmune diseases, and the development and selection of B cells. Adverse immunological reactions to self and foreign antigens that lead to autoimmune or inflammatory disease place a major economic and social burden on world health and individual quality of life. We are also interested in how people differ in their inherited susceptibility to these diseases and why these differences are sustained in human populations by natural selection. Advances in this area will have a large and impact on the management of human disease.
Our strategy involves research programmes in basic biology and in clinical medicine. In the first, we use transgenic models to investigate how lymphocytes function in health and in human disease and how our genes encode susceptibility to autoimmunity and immunodeficiency. In the second, which is a collaboration with Professor Simon Davis, we are developing ways to change the function of lymphocytes, turning them on in cancer and off during inflammation or autoimmunity.
An essential role for the Zn2+ transporter ZIP7 in B cell development
Anzilotti C. et al, (2019), Nature Immunology, 20, 350 - 361
53BP1 cooperation with the REV7-shieldin complex underpins DNA structure-specific NHEJ.
Ghezraoui H. et al, (2018), Nature, 560, 122 - 127
Partial retinal photoreceptor loss in a transgenic mouse model associated with reduced levels of interphotoreceptor retinol binding protein (IRBP, RBP3).
Liu Y-H. et al, (2018), Exp Eye Res, 172, 54 - 65
Capturing resting T cells: the perils of PLL.
Santos AM. et al, (2018), Nat Immunol, 19, 203 - 205
NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease
Schwerd T. et al, (2018), Mucosal Immunology, 11, 562 - 574